These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 10068682)

  • 1. Immunosurveillance of alglucerase enzyme therapy for Gaucher patients: induction of humoral tolerance in seroconverted patients after repeat administration.
    Rosenberg M; Kingma W; Fitzpatrick MA; Richards SM
    Blood; 1999 Mar; 93(6):2081-8. PubMed ID: 10068682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a panel of highly sensitive, equivalent assays for detection of antibody responses to velaglucerase alfa or imiglucerase enzyme replacement therapy in patients with Gaucher disease.
    Séllos-Moura M; Barzegar S; Pan L; Shi P; Oommen S; Durant J; Ruiz JA
    J Immunol Methods; 2011 Oct; 373(1-2):45-53. PubMed ID: 21846471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enzyme therapy of gaucher disease: clinical and biochemical changes during production of and tolerization for neutralizing antibodies.
    Zhao H; Bailey LA; Grabowski GA
    Blood Cells Mol Dis; 2003; 30(1):90-6. PubMed ID: 12667990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enzyme therapy in Gaucher disease type 1: effect of neutralizing antibodies to acid beta-glucosidase.
    Ponce E; Moskovitz J; Grabowski G
    Blood; 1997 Jul; 90(1):43-8. PubMed ID: 9207436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody response in patients with Gaucher disease after repeated infusion with macrophage-targeted glucocerebrosidase.
    Richards SM; Olson TA; McPherson JM
    Blood; 1993 Sep; 82(5):1402-9. PubMed ID: 8364193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutation analysis of the acid beta-glucosidase gene in a patient with type 3 Gaucher disease and neutralizing antibody to alglucerase.
    Germain DP; Kaneski CR; Brady RO
    Mutat Res; 2001 Nov; 483(1-2):89-94. PubMed ID: 11600137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gaucher's disease: lack of antibody response to intravenous glucocerebrosidase.
    Britton DE; Leinikki PO; Barranger JA; Brady RO
    Life Sci; 1978 Dec; 23(25):2517-9. PubMed ID: 732537
    [No Abstract]   [Full Text] [Related]  

  • 8. Enzyme therapy in type 1 Gaucher disease: comparative efficacy of mannose-terminated glucocerebrosidase from natural and recombinant sources.
    Grabowski GA; Barton NW; Pastores G; Dambrosia JM; Banerjee TK; McKee MA; Parker C; Schiffmann R; Hill SC; Brady RO
    Ann Intern Med; 1995 Jan; 122(1):33-9. PubMed ID: 7985893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gaucher's disease: lack of antibody response in 12 patients following repeated intravenous infusions of mannose terminal glucocerebrosidase.
    Murray GJ; Howard KD; Richards SM; Barton NW; Brady RO
    J Immunol Methods; 1991 Mar; 137(1):113-20. PubMed ID: 2010615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of neutralizing antibody to Ceredase in a patient with type 3 Gaucher disease.
    Brady RO; Murray GJ; Oliver KL; Leitman SF; Sneller MC; Fleisher TA; Barton NW
    Pediatrics; 1997 Dec; 100(6):E11. PubMed ID: 9382912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of anti-velaglucerase alfa antibodies in clinical trial-treated patients with Gaucher disease.
    Pastores GM; Turkia HB; Gonzalez DE; Ida H; Tantawy AA; Qin Y; Qiu Y; Dinh Q; Zimran A
    Blood Cells Mol Dis; 2016 Jul; 59():37-43. PubMed ID: 27282565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enzyme therapy in Gaucher disease type 1: dosage efficacy and adverse effects in 33 patients treated for 6 to 24 months.
    Pastores GM; Sibille AR; Grabowski GA
    Blood; 1993 Jul; 82(2):408-16. PubMed ID: 8392397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alglucerase. A pharmacoeconomic appraisal of its use in the treatment of Gaucher's disease.
    Whittington R; Goa KL
    Pharmacoeconomics; 1995 Jan; 7(1):63-90. PubMed ID: 10155294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anaphylactoid reaction to imiglucerase, but not to alglucerase, in a type I Gaucher patient.
    Aviner S; Levy Y; Yaniv I; Cohen IJ
    Blood Cells Mol Dis; 1999 Apr; 25(2):92-4. PubMed ID: 10389590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunoglobulin abnormalities and effects of enzyme replacement therapy in children with Gaucher disease.
    Arıkan-Ayyıldız Z; Yuce A; Uslu-Kızılkan N; Demir H; Gurakan F
    Pediatr Blood Cancer; 2011 Apr; 56(4):664-6. PubMed ID: 21298757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperimmunoglobulinemia in pediatric-onset type 1 Gaucher disease and effects of enzyme replacement therapy.
    Wine E; Yaniv I; Cohen IJ
    J Pediatr Hematol Oncol; 2007 Jul; 29(7):451-7. PubMed ID: 17609622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The long-term international safety experience of imiglucerase therapy for Gaucher disease.
    Starzyk K; Richards S; Yee J; Smith SE; Kingma W
    Mol Genet Metab; 2007 Feb; 90(2):157-63. PubMed ID: 17079176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transformation in pretreatment manifestations of Gaucher disease type 1 during two decades of alglucerase/imiglucerase enzyme replacement therapy in the International Collaborative Gaucher Group (ICGG) Gaucher Registry.
    Mistry PK; Batista JL; Andersson HC; Balwani M; Burrow TA; Charrow J; Kaplan P; Khan A; Kishnani PS; Kolodny EH; Rosenbloom B; Scott CR; Weinreb N
    Am J Hematol; 2017 Sep; 92(9):929-939. PubMed ID: 28569047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alglucerase. A review of its therapeutic use in Gaucher's disease.
    Whittington R; Goa KL
    Drugs; 1992 Jul; 44(1):72-93. PubMed ID: 1379912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Safety of use of velaglucerase in 2 patients with type 1 Gaucher's disease].
    Latre P; Giraldo P
    Med Clin (Barc); 2011 Sep; 137 Suppl 1():39-42. PubMed ID: 22230124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.